Preventing SARS-CoV-2 infection by blocking a tissue serine protease

Currently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID-19) pandemic. Selecting specific pharmacologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankousky, Katherine C., Schultz, Jonathan, Windham, Samuel, Henao-Martínez, Andrés F., Franco-Paredes, Carlos, Shapiro, Leland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288835/
https://www.ncbi.nlm.nih.gov/pubmed/32577236
http://dx.doi.org/10.1177/2049936120933076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288835/
https://www.ncbi.nlm.nih.gov/pubmed/32577236
http://dx.doi.org/10.1177/2049936120933076

Ejemplares similares